Paul Wei‐Che Hsu
- Cancer Research top 5%
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 4
- Single-cell and spatial transcriptomics 2
- Mitochondrial Function and Pathology 2
- Virology top 10%
- Cell Biology top 10%
-
- interferon and immune responses 3
- IL-33, ST2, and ILC Pathways 2
- Immune Cell Function and Interaction 2
-
- Autophagy in Disease and Therapy 3
-
- Virus-based gene therapy research 2
- Co-authors
- Yuguang ShiChun‐Ming ChenYu-Lun LiaoJui-Ling WangGar‐Yang ChauHsien‐Da HuangAnn‐Ping TsouChing‐Wen Lin
- Partner nations
- TaiwanUnited StatesAustria
In The Last Decade
Paul Wei‐Che Hsu
21 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 585
- Endocrine and Autonomic Systems 118
- Molecular Biology 1.2k
- Virology 38
- Cell Biology 124
Countries citing papers authored by Paul Wei‐Che Hsu
This map shows the geographic impact of Paul Wei‐Che Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Wei‐Che Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Wei‐Che Hsu more than expected).
Fields of papers citing papers by Paul Wei‐Che Hsu
This network shows the impact of papers produced by Paul Wei‐Che Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Wei‐Che Hsu. The network helps show where Paul Wei‐Che Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Wei‐Che Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 35 | |
| 6 | 2021 | 25 | |
| 7 | 2017 | 16 | |
| 8 | 2016 | 71 | |
| 9 | 2015 | 93 | |
| 10 | 2015 | 21 | |
| 11 | 2014 | 22 | |
| 12 | 2014 | 4 | |
| 13 | 2013 | 120 | |
| 14 | 2012 | 4 | |
| 15 | 2012 | 28 | |
| 16 | 2012 | 85 | |
| 17 | 2011 | 37 | |
| 18 | 2011 | 345 | |
| 19 | 2008 | 492 | |
| 20 | 2005 | 165 |
About Paul Wei‐Che Hsu
Paul Wei‐Che Hsu is a scholar working on Virology, Immunology and Molecular Biology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), interferon and immune responses (3 papers), Autophagy in Disease and Therapy (3 papers), Virus-based gene therapy research (2 papers), Single-cell and spatial transcriptomics (2 papers), Mitochondrial Function and Pathology (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (585 citations), Endocrine and Autonomic Systems (118 citations) and Molecular Biology (1.2k citations). Paul Wei‐Che Hsu has collaborated with scholars based in Taiwan, United States and Austria. Frequent co-authors include Yuguang Shi, Chun‐Ming Chen, Yu-Lun Liao, Jui-Ling Wang, Gar‐Yang Chau, Hsien‐Da Huang, Ann‐Ping Tsou, Ching‐Wen Lin, Yat‐Pang Chau and Michael Hsiao. Their work appears in journals such as Cell, Journal of Virology, Autophagy, Scientific Reports and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.